Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Jul;95(28):e4225.
doi: 10.1097/MD.0000000000004225.

Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis

Affiliations
Meta-Analysis

Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis

Yibin Guo et al. Medicine (Baltimore). 2016 Jul.

Abstract

The aim of this study is to summarize the evidence on the dose-response relationship between body mass index (BMI) and mortality in patients with chronic obstructive pulmonary disease (COPD).We performed a systemic literature search in PubMed, Embase, and Web of Science for relevant studies that were published until June 2015. A random effects meta-analysis was used to estimate the pooled relative risks (RRs) of all-cause mortality in COPD patients with normal weight compared with those who were underweight, overweight, or obese. In addition, a dose-response meta-analysis was conducted to explore the dose-response relationship between BMI and all-cause mortality in COPD patients.A total of 17 observational studies involving 30,182 COPD patients among 285,960 participants were included. Compared with the reference category, the RRs of underweight, overweight, and obese individuals were 1.40 (95% confidence interval (CI), 1.20-1.63), 0.80 (95% CI, 0.67-0.96), and 0.77 (95% CI, 0.62-0.95), respectively. A significant nonlinear relationship between BMI and mortality of COPD patients was found by using a random effects model. COPD patients with BMI of <21.75 kg/m had a higher risk of death. Moreover, an increase in the BMI resulted in a decrease in the risk of death. The risk of death was lowest when BMI was 30 kg/m (RR = 0.69; 95% CI, 0.53-0.89). The BMI was not associated with all-cause mortality when BMI was >32 kg/m.Our findings indicate that overweight is associated with a lower risk of all-cause mortality among patients with COPD whereas underweight is associated with a higher risk of all-cause mortality in these patients. However, there is limited evidence to support the association between obesity and the risk of all-cause mortality in patients with COPD.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Literature search and study selection.
Figure 2
Figure 2
Summary of relative risks of all-cause mortality in underweight COPD patients. COPD = chronic obstructive pulmonary disease.
Figure 3
Figure 3
Summary of relative risks of all-cause mortality in overweight COPD patients. COPD = chronic obstructive pulmonary disease.
Figure 4
Figure 4
Summary of relative risks of all-cause mortality in obese COPD patients. COPD = chronic obstructive pulmonary disease.
Figure 5
Figure 5
Dose–response relationship between BMI score and risk of all-cause mortality. BMI = body mass index.
Figure 6
Figure 6
Subgroup analysis stratifying by age, follow up, and study design.

References

    1. The Asia Pacific COPD Roundtable Group. Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: An Asia–Pacific perspective. Respirology 2005; 10:9–17. - PMC - PubMed
    1. Flegal KM, Kit BK, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309:71–82. - PMC - PubMed
    1. Cao C, Wang R, Wang JM, et al. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PloS One 2012; 7:8. - PMC - PubMed
    1. Liu XM, Liu YJ, Zhan J, et al. Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a dose–response meta-analysis of prospective cohort studies. Eur J Epidemiol 2014; 30:35–45. - PubMed
    1. Bagheri M, Speakman JR, Shabbidar S, et al. A dose–response meta-analysis of the impact of body mass index on stroke and all-cause mortality in stroke patients: a paradox within a paradox. Obes Rev 2015; 16:416.23. - PubMed

Publication types